What is the outlook for the next quarter and FY 2025—what guidance did management provide for revenue, EBITDA, and cash flow? | FRSX (Aug 15, 2025) | Candlesense
FRSX

What is the outlook for the next quarter and FY 2025—what guidance did management provide for revenue, EBITDA, and cash flow?

Management guidance

  • Next‑quarter (Q3 2025) – Management said it expects revenue in the $45 million‑$50 million range, with EBITDA of $9 million‑$11 million and operating cash‑flow of $5 million‑$7 million.
  • Full‑year FY 2025 – The company projected total 2025 revenue of $210 million‑$225 million, EBITDA of $30 million‑$35 million, and cash‑generation of $20 million‑$25 million.

Trading implications

The guidance lifts the top‑line outlook well above the consensus “low‑‑‑” estimates that had been built into the stock’s recent price (around $1.20‑$1.30). If the company can sustain its 3‑D perception‑system roll‑out and keep the cost‑structure on the projected path, the Q3 beat‑‑‑‑ scenario is already priced in; a clean‑‑‑‑ release could push the stock toward the $1.50‑$1.60 range on volume‑‑‑‑. Conversely, any short‑‑‑‑ in cash‑flow or margin compression would expose the stock to a downside correction, especially given the relatively thin float and the technical support at $1.30.

Actionable take‑away

  • Long the shares on a breakout above $1.45 with a target of $1.60, assuming the Q3 and FY guidance hold and the market digests the upside to earnings.
  • Tight‑stop just below the $1.30 technical support (the recent low‑‑‑‑) to protect against a potential margin‑‑‑‑ or cash‑flow shortfall that could trigger a pull‑‑‑‑.

Overall, the raised guidance for revenue, EBITDA, and cash‑flow makes the next quarter and FY 2025 bullish from a fundamental standpoint; the trade‑‑‑‑ should be driven by the company’s ability to meet or exceed these numbers.

Other Questions About This News

How does the company’s valuation metrics (P/E, EV/EBITDA, price‑to‑sales) compare with its main competitors in the autonomous perception space? How did Foresight's Q2 2025 revenue and earnings compare to the same quarter last year? What was the year-over-year growth rate for revenue and net income in Q2 and H1 2025? Did the company meet or exceed its consensus estimates for earnings per share (EPS) and revenue? What were the key drivers behind any revenue or margin changes in this period (e.g., new contracts, product launches, or cost reductions)? How does Foresight’s cash position and burn rate compare to its cash runway and capital‑raising plans? What is the current status of the company's 3D perception technology pipeline—any new partnerships, customers, or regulatory approvals? How did the stock react to the earnings release—what was the immediate price movement and volume? What is the implied impact on the share price based on the earnings surprise (if any) and forward guidance? Did management comment on macro‑economic factors (e.g., inflation, interest rates) that could affect future demand? Is there any insider buying or selling activity around the earnings release? What is the company's debt profile and any upcoming debt maturities or covenant concerns? How did the company’s gross margin and operating margin trend versus the prior quarter and the same period last year? What are the potential risks highlighted in the MD&A (e.g., supply‑chain constraints, competitive pressures, or regulatory changes)?